Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors

References

• Rini BI, Campbell SC. Renal cell carcinoma. Shelton, Conn.: People's Medical Pub. House; 2009.
   Google Scholar
• Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34:193–205. DOI:10.1016/j.ctrv.2007.12.001.
   PubMed Web of Science ®Google Scholar
• Permpongkosol S, Chan DY, Link RE, et al. Laparoscopic radical nephrectomy: long-term outcomes. J Endourol. 2005;19:628–633. DOI:10.1089/end.2005.19.628.
   PubMed Web of Science ®Google Scholar
• Crawford J, Becker PS, Armitage JO, et al. Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15:1520–1541.
   PubMed Web of Science ®Google Scholar
• Psutka SP, Feldman AS, McDougal WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63:486–492.
   PubMed Web of Science ®Google Scholar
• Takaki H, Yamakado K, Soga N, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol. 2010;28:460–468.
   PubMed Web of Science ®Google Scholar
• Lucas SM, Stern JM, Adibi M, et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008;179:75–79. discussion 79-80.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Park BK, Park JJ, et al. CT-guided radiofrequency ablation of T1a renal cell carcinoma in Korea: mid-term outcomes. Korean J Radiol. 2016;17:763–770. PubMed PMID: 27587966; PubMed Central PMCID: PMCPMC5007404.
   PubMed Web of Science ®Google Scholar
• Thompson RH, Atwell T, Schmit G, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67:252–259.
   PubMed Web of Science ®Google Scholar
• Atwell TD, Schmit GD, Boorjian SA, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013;200:461–466.
   PubMed Web of Science ®Google Scholar
• Wah TM, Irving HC, Gregory W, et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 2014;113:416–428. PubMed PMID: 24053769; PubMed Central PMCID: PMCPMC4233988.
   PubMed Web of Science ®Google Scholar
• Balageas P, Cornelis F, Le Bras Y, et al. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients. Eur Radiol. 2013;23:1925–1932.
   PubMed Web of Science ®Google Scholar
• Iannuccilli JD, Dupuy DE, Beland MD, et al. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients. Eur Radiol. 2016;26:1656–1664.
   PubMed Web of Science ®Google Scholar
• Alguersuari A, Mateos A, Falco J, et al. Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years' experience. Radiologia. 2016;58:373–379.
   PubMed Web of Science ®Google Scholar
• Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol. 2014;37:1494–1499.
   PubMed Web of Science ®Google Scholar
• Tsivian M, Lyne JC, Mayes JM, et al. Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation. Urology. 2010;75:307–310.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007;188:480–488.
   PubMed Web of Science ®Google Scholar
• Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106:316–321.
   PubMed Web of Science ®Google Scholar
• Klapperich ME, Abel EJ, Ziemlewicz TJ, et al. Effect of tumor complexity and technique on efficacy and complications after percutaneous microwave ablation of stage T1a renal cell carcinoma: a single-center, retrospective study. Radiology. 2017;284:272. PubMed PMID: 28076721; PubMed Central PMCID: PMCPMC5495130.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu XL, et al. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Radiology. 2012;263:900–908.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Yu X, Han Z, et al. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study. Int J Hyperthermia. 2018;34(3):315–320. DOI:10.1080/02656736.2017.1338362
   PubMed Web of Science ®Google Scholar
• Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol. 2007;30:936–942. PubMed PMID: 17573550; PubMed Central PMCID: PMCPMC2700242.
   PubMed Web of Science ®Google Scholar
• Farrell MA, Charboneau JW, Callstrom MR, et al. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181:1315–1317.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260. PubMed PMID: 24927329; PubMed Central PMCID: PMCPMC4263618.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu X, et al. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2011;79:124–130.
   PubMed Web of Science ®Google Scholar
• Tracy CR, Raman JD, Donnally C, et al. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116:3135–3142.
   PubMed Web of Science ®Google Scholar
• Lyrdal D, Andersson M, Hellstrom M, et al. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: clinical results and radiological evolution during follow-up. Acta Radiol. 2010;51:808–818.
   PubMed Web of Science ®Google Scholar
• Zagoria RJ, Pettus JA, Rogers M, et al. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77:1393–1397.
   PubMed Web of Science ®Google Scholar
• Mues AC, Okhunov Z, Haramis G, et al. Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses. J Endourol. 2010;24:1097–1100.
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Cizman Z, Hong K, et al. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Intervent Radiol. 2011;34:573–578.
   PubMed Web of Science ®Google Scholar
• Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer. 2008;113:2671–2680. PubMed PMID: 18816624; PubMed Central PMCID: PMCPMC2704569.
   PubMed Web of Science ®Google Scholar
• Chalasani V, Martinez CH, Lim D, et al. Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. CUAJ. 2010;4:399–402. PubMed PMID: 21191499; PubMed Central PMCID: PMCPMC2997831.
   Google Scholar
• Jilg CA, Neumann HP, Glasker S, et al. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma. Urol Int. 2012;88:71–78.
   PubMed Web of Science ®Google Scholar
• Caputo PA, Ramirez D, Zargar H, et al. Laparoscopic cryoablation for renal cell carcinoma: 100-month oncologic outcomes. J Urol. 2015;194:892–896.
   PubMed Web of Science ®Google Scholar